A history of the treatment of primary liver cancer.
作者信息
Bruix Jordi
机构信息
Barcelona Clínic Liver Cancer (BCLC), Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
出版信息
Clin Liver Dis (Hoboken). 2024 May 3;23(1):e0147. doi: 10.1097/CLD.0000000000000147. eCollection 2024 Jan-Jun.
Abstract
摘要
相似文献
1
A history of the treatment of primary liver cancer.原发性肝癌的治疗史。
Clin Liver Dis (Hoboken). 2024 May 3;23(1):e0147. doi: 10.1097/CLD.0000000000000147. eCollection 2024 Jan-Jun.
2
Liver-First Resection in Patients With Synchronous Colorectal Liver Metastases Is Associated With Inferior Recurrence-Free Survival: Reconsidering the Importance of the Primary Cancer.同步性结直肠癌肝转移患者先行肝切除与无复发生存期较差相关：重新审视原发性癌症的重要性。
Dis Colon Rectum. 2025 Jan 1;68(1):32-40. doi: 10.1097/DCR.0000000000003518. Epub 2024 Sep 12.
3
History of keratinocyte carcinoma and survival after a second primary malignancy: the Moffitt Cancer Center patient experience.角化细胞癌病史和第二原发恶性肿瘤后的生存情况：莫菲特癌症中心患者的经验。
J Cancer Res Clin Oncol. 2023 Jul;149(7):3607-3621. doi: 10.1007/s00432-022-04210-y. Epub 2022 Aug 13.
4
Real-world outcomes of selective internal radiation therapy with Y resin microspheres in HCC/mCRC: RESIN registry Asia.Y树脂微球选择性内放射治疗在肝癌/结直肠癌中的真实世界疗效：RESIN亚洲注册研究
Future Oncol. 2025 Jul 15:1-11. doi: 10.1080/14796694.2025.2524862.
5
Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.生殖因素、绝经激素治疗与原发性肝癌风险：观察性研究的系统评价和剂量-反应荟萃分析。
Hum Reprod Update. 2016 Dec;23(1):126-138. doi: 10.1093/humupd/dmw037. Epub 2016 Sep 21.
6
Hepatic abscess caused by foreign body ingestion: A case report.异物摄入导致的肝脓肿：一例报告。
Australas J Ultrasound Med. 2025 Feb 17;28(1):e12422. doi: 10.1002/ajum.12422. eCollection 2025 Feb.
7
Association of estimated glucose disposal rate with risk of future metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases: a prospective cohort study.估计葡萄糖处置率与未来代谢功能障碍相关脂肪性肝病及其他慢性肝病风险的关联：一项前瞻性队列研究
Front Med (Lausanne). 2025 Jul 2;12:1589245. doi: 10.3389/fmed.2025.1589245. eCollection 2025.
8
[Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].[中药治疗肝癌患者经动脉化疗栓塞术副作用的系统评价与Meta分析]
Zhong Xi Yi Jie He Xue Bao. 2012 Dec;10(12):1341-62. doi: 10.3736/jcim20121204.
9
Prediagnostic plasma metabolite concentrations and liver cancer risk: A nested case-control study with long follow-up in the Shanghai Women's Health Study.诊断前血浆代谢物浓度与肝癌风险：上海女性健康研究中的一项长期随访巢式病例对照研究。
Int J Cancer. 2025 Jun 23. doi: 10.1002/ijc.70004.
10
Robotic versus open surgery for simultaneous resection of rectal cancer and liver metastases: a randomized controlled trial.机器人与开放手术治疗直肠癌合并肝转移的同期切除：一项随机对照试验。
Int J Surg. 2023 Nov 1;109(11):3346-3353. doi: 10.1097/JS9.0000000000000581.
引用本文的文献
1
The liver in Judaism.犹太教中的肝脏。
Clin Liver Dis (Hoboken). 2024 Jun 25;23(1):e0234. doi: 10.1097/CLD.0000000000000234. eCollection 2024 Jan-Jun.
2
Interventional radiology and the liver vasculature: A personal perspective.介入放射学与肝脏血管系统：个人观点。
Clin Liver Dis (Hoboken). 2024 Jun 25;23(1):e0239. doi: 10.1097/CLD.0000000000000239. eCollection 2024 Jan-Jun.
本文引用的文献
1
The liver in Greco-Arabic and Islamic medicine.希腊-阿拉伯医学和伊斯兰医学中的肝脏。
Clin Liver Dis (Hoboken). 2024 Apr 4;23(1):e0137. doi: 10.1097/CLD.0000000000000137. eCollection 2024 Jan-Jun.
2
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.特瑞利木单抗联合度伐利尤单抗治疗不可切除肝细胞癌。
NEJM Evid. 2022 Aug;1(8):EVIDoa2100070. doi: 10.1056/EVIDoa2100070. Epub 2022 Jun 6.
3
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.阿替利珠单抗联合贝伐珠单抗对比主动监测用于治疗接受手术切除或消融治疗的高风险肝细胞癌患者（IMbrave050）：一项随机、开放标签、多中心、III 期临床试验。
Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20.
4
Professor Leslie H. Blumgart-Pioneering Hepatopancreaticobiliary Surgeon: a Tribute.莱斯利·H·布卢姆加特教授——开创性的肝胰胆外科医生：一篇颂词。
Indian J Surg. 2022 Oct 27:1-3. doi: 10.1007/s12262-022-03601-2.
5
Reevaluation of Makuuchi's criteria for resecting hepatocellular carcinoma: A Japanese nationwide survey.对幕内标准在肝细胞癌切除术中应用的重新评估：一项日本全国性调查。
Hepatol Res. 2023 Feb;53(2):127-134. doi: 10.1111/hepr.13844. Epub 2022 Oct 18.
6
Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group.用于肝细胞癌的 Y-90 玻璃微球的临床、剂量学和报告考虑因素：国际多学科工作组的 2022 年更新建议。
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):328-343. doi: 10.1007/s00259-022-05956-w. Epub 2022 Sep 17.
7
Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial).手术与射频消融治疗小肝癌：一项随机对照试验（SURF试验）。
Liver Cancer. 2021 Dec 29;11(3):209-218. doi: 10.1159/000521665. eCollection 2022 Jun.
8
Survival Benefit of Living-Donor Liver Transplant.活体肝移植的生存获益。
JAMA Surg. 2022 Oct 1;157(10):926-932. doi: 10.1001/jamasurg.2022.3327.
9
Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti-VEGF/TKI and immunotherapy.系统联合抗血管生成/TKI 和免疫治疗时代的肝癌肝移植降期治疗。
Hepatology. 2022 Oct;76(4):1203-1218. doi: 10.1002/hep.32613. Epub 2022 Jul 30.
10
Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the United States: An Analysis of the OPTN/UNOS Database.美国肝移植中丙型肝炎阳性供体的利用情况存在差异，但结局更优：OPTN/UNOS 数据库分析。
Transplantation. 2022 Sep 1;106(9):1787-1798. doi: 10.1097/TP.0000000000004116. Epub 2022 Apr 6.
Zotero 插件